LSZ 150 mcg Blotters (Lysergic Acid Derivative) – Scientific Product Description

Uvod

LSZ (Lysergic Acid 2,4-dimethylazetidide) is a semi-synthetic lysergamide, structurally related to LSD. These 150 mcg blotters were developed for use in strictly controlled laboratory environments and are intended for research into the pharmacological properties ili psychedelic compounds. Production takes place under strict quality control.

Tehničke specifikacije

• Active ingredient: LSZ (Lysergic Acid 2,4-dimethylazetidide)
• Dosage per blotter: 150 ± 5 mcg
• Blotter size: 5×5 mm, perforated squares
• Carrier medium: High-quality chromatography paper
• Čistoća: ≥98% (analiza HPLC-om)
• Shelf life: 24 months when stored between 2–8°C in a light-proof container.

Istraživačke primjene

LSZ blotters are used in:

• Receptor binding studies targeting 5-HT2A agonism
• Comparative pharmacological analysis within the lysergamide class
• Dose-response studies in controlled models
• Metabolic stability studies in vitro

Kontrola kvalitete

Svaka serija podliježe:

• HPLC-UV quantification of active substance
• Confirmation via mass spectrometry
• Dosage uniformity analysis
• Microbiological control of the carrier material

Sigurnosni protokol

Rukovanje

• Use nitrile gloves for all handling
• Avoid direct contact with skin
• Work only in a controlled laboratory environment
• Wear protective clothing, goggles and, if necessary, respiratory protection

Pohrana

• Temperature: 2–8°C
• Protection from light and moisture is required
• Use only the original, sealed packaging

Regulatorni okvir

• Classified under the Dutch Opium Act (Schedule I)
• Only permitted for licensed research institutions
• Nije prikladno za ljudsku konzumaciju
• Export and distribution subject to regulations

Podaci o narudžbi

• Packaging unit: 10 blotters per sheet
• Delivery: Refrigerated transport with temperature registration
• Documentation: COA and full analytical specifications available per batch

Znanstvene reference

• Nichols (2016.) – Psihodelici kao lijekovi
• Brandt i dr. (2020.) – Farmakologija lisergamida
• EMCDDA (2023.) – Tehničko izvješće o novim psihoaktivnim tvarima

Važna napomena

This product is intended solely for legally authorized scientific research. Sale and use are restricted to qualified professionals within a regulated research environment. The purchaser is solely responsible for compliance with applicable laws and regulations.

1cP-LSD 150 MCG Art Blotters O-DSMT pelete od 50 mg 1V-LSD 150 MCG upijajućih papira 6-CL-ADBA 2-CMC pelete od 250 mg